Skip to content

CAM in Hospice Palliative Care in Taiwan

The Application of Evidence-Based Chinese Complementary and Alternative Medicine (CAM) in Hospice Palliative Care in Taiwan-The Second and Third Year Project.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02663063
Enrollment
60
Registered
2016-01-26
Start date
2015-12-31
Completion date
2017-09-30
Last updated
2023-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Complementary and alternative medicine, Hospice Palliative Care

Brief summary

The study aims to explore the effects of silver spike point (SSP) treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients.

Detailed description

The study aims to explore the effects of silver spike point treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients. We will conducted a pilot study to evaluate the effects on different symptoms and then a prospective study will be conducted after validation of major effects.

Interventions

DEVICESSP treatment

SSP treatment 5 times a week

Sponsors

Taipei Veterans General Hospital, Taiwan
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Cancer patients * Competent with clear consciousness * With symptoms of pain, breathlessness, nause/vomiting, dry mouth, generalized discomfort * Expected life span of at least 1 week

Exclusion criteria

* With implanted devices * Not having clear consciousness * Expected life span less than 1 week * Foreigner

Design outcomes

Primary

MeasureTime frameDescription
Symptom severity scoreOne week after treatmentQuestionnaire for evaluating the severity of symptoms

Secondary

MeasureTime frameDescription
Quality of lifeOne week after treatmentQuestionnaire for evaluating quality of life

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026